Glyconics

About:

Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.

Website: http://www.glyconics.com/

Top Investors: Innovate UK, Deepbridge Capital, Wealth Club, Boundary Capital Partners LLP, SBRI Healthcare

Description:

Glyconics Ltd is an innovative diagnostics company which has developed a novel approach to the diagnosis and monitoring of chronic and acute diseases including respiratory disease. The new device uses fourier transform infrared spectroscopy (FITR) to analyse sputum (saliva) samples for specific biomarkers, characteristic of chronic obstructive pulmonary disease (COPD).

Total Funding Amount:

1.75M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)glyconics.com

Founders:

Berwyn Clarke

Number of Employees:

1-10

Last Funding Date:

2021-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai